Evolent Health Inc (NYSE:EVH)
$ 22.5 0.47 (2.13%) Market Cap: 2.58 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 66/100

Evolent Health Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 11:00PM GMT
Release Date Price: $10.1 (-4.81%)
Anne Elizabeth Samuel
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everybody. Welcome to the Evolent Health presentation of the JPMorgan Health Care Conference. My name is Annie Samuel, and I cover health care IT here at JPMorgan.

With us this afternoon is President, Seth Blackley; CEO and Co-Founder, Frank Williams; and CFO, John Johnson. We'll be taking questions after the presentation across the hall in the Georgian Room. And with that, let me turn it over to Frank.

Frank J. Williams
Evolent Health, Inc. - Co-Founder, CEO & Chairman

Great. Thanks everyone for being here. I know it's been a long conference, long day so we'll try to be, I don't know, interesting, funny, something to lighten the room a little bit. A lot of blue suits out there but good to be here.

We tend to use the conference where we tend to have some new people to the story to just give a little context for Evolent's business. And again, many of you are familiar with these themes. But really, when you think about the big problem in U.S.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot